LakeShore Biopharma Co., Ltd (LSB)

USD 2.45

(-3.22%)

Market Cap (In USD)

46.81 Million

Revenue (In USD)

573.41 Million

Net Income (In USD)

-433.46 Million

Avg. Volume

35 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.88-11.2
PE
-
EPS
-
Beta Value
0.74
ISIN
KYG9845F1090
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Wang Xu
Employee Count
-
Website
https://www.ysbiopharm.com
Ipo Date
2021-08-05
Details
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.